Cleared Traditional

K141830 - STIMULAN KIT, STIMULAN RAPID CURE

K141830 is an FDA 510(k) clearance for STIMULAN KIT, manufactured by Biocomposites, Ltd.. The device is a Class 2 Orthopedic device with product code MQV cleared through the Traditional 510(k) pathway after a 200-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2015
Decision
200d
Days
Class 2
Risk

K141830 is an FDA 510(k) clearance for the STIMULAN KIT, STIMULAN RAPID CURE. Classified as Filler, Bone Void, Calcium Compound (product code MQV), Class II - Special Controls.

Submitted by Biocomposites, Ltd. (Keele, GB). The FDA issued a Cleared decision on January 23, 2015 after a review of 200 days - an extended review cycle.

This device falls under the Orthopedic FDA review panel, regulated under 21 CFR 888.3045 - the FDA orthopedic device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Orthopedic review framework, consistent with the majority of Class II 510(k) submissions.

View all Biocomposites, Ltd. devices

FDA 510(k) Submission Details - K141830

510(k) Number K141830 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 07, 2014
Decision Date January 23, 2015
Days to Decision 200 days
Submission Type Traditional
Review Panel Orthopedic (OR)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
78d slower than avg
Panel avg: 122d · This submission: 200d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

MQV Device Classification - Class 2, Special Controls

Product Code MQV Filler, Bone Void, Calcium Compound
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 888.3045
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Orthopedic devices follow this clearance model.

Regulatory Peers - MQV Filler, Bone Void, Calcium Compound

All 399
Devices cleared under the same product code (MQV) and FDA review panel - the closest regulatory comparables to K141830.
CARRICELL
K132868 · Etex Corporation · Feb 2015
NUROS BONE GRAFT SUBSTITUTE
K140913 · Oriental Resources Development Limited · Feb 2015
NANOBONE / GRANULATE
K141189 · Artoss GmbH · Jan 2015
NANOFUSE DBM
K142104 · Nanotherapeutics, Inc. · Jan 2015
MCS Bone Graft
K142276 · Biostructures, LLC · Jan 2015
osteoSPAN Morpheus
K142828 · Biogennix · Jan 2015